Product
IkT-001Pro
1 clinical trial
1 indication
Indication
Chronic Myeloid LeukemiaClinical trial
A Dose Calibration and Dose Equivalence Pharmacokinetic Study in Healthy Volunteers Comparing IkT-001Pro to Imatinib Mesylate 400mgStatus: Recruiting, Estimated PCD: 2023-12-31